Arvinas (ARVN) Competitor Comparison
We are evaluating the key criteria listed to compare Arvinas (ARVN) against its competitors in the Biotechnology industry.
Market Capitalization
56 / 368Gross Profits
42 / 278Total Revenue
68 / 300EBITDA
302 / 337Free Cashflow
202 / 352Quick Ratio
256 / 357Earnings per Share
295 / 359Dividend yield
0 / 6Total Cash
24 / 358Performance 3 years
200 / 368Performance 5 years
142 / 368Performance 10 years
91 / 368Linearity 3 years
159 / 368Linearity 5 years
35 / 368Linearity 10 years
37 / 368Total Rank
293 / 368Dividend Rank
363 / 368Valuation Rank
185 / 368Piotroski Rank
341 / 368Muliplier Rank
280 / 368Performance 5 years - ARVN ranking 142 / 368
Obligatory risk notice
We would like to point out that the contents of this website are for general information purposes only and do not constitute recommendations for the purchase or sale of specific financial instruments, and therefore do not constitute investment advice. In particular, marketstorylabs.com and its creators cannot assess the extent to which information / recommendations made on the pages correspond to your investment objectives, your risk tolerance and your ability to bear losses. Therefore, if you make any investment decisions based on information on the site, you do so solely on your own responsibility and at your own risk. This in turn means that neither marketstorylabs.com nor its creators are liable for any losses incurred as a result of investment decisions based on the information on the marketstorylabs.com website or other media used.